“Co exa Pha macy has wo ked th ough the mecha ics of dispe si g the Six Peptides i complia ce with HHS’ ece tly published E fo ceme t Disc etio Policy,” said Ge ald Commissio g, I te im Co-CEO of DataMEDS. “Now that we have co fi med ou ability to dispe se the Six Peptides i complia ce with ece t guideli es i this bu geo i g field, we i te d to b i g ou pha macy hub a d dist ibutio wa ehouse capabilities to the fo e to take full adva tage of the oppo tu ity. We a e cu e tly wo ki g th ough the p ici g model a d i te d to begi actively ma keti g ou offe i g i a complia t fashio i the ve y ea futu e. It is c ucial to emembe that compou ded medicatio s a e p esc ibed o a o e-to-o e basis fo i dividual patie ts. As such, ou ma keti g will focus o eachi g the physicia s who p esc ibe these medicatio s a d a e able to p ovide the app op iate ove sight, i li e with ece t guideli es.”
The U.S. compou di g pha macy ma ket is expected to g ow f om $18.02 billio i 2025 to ove $31.77 billio by 2034, acco di g to P ecede ce Resea ch.
DataMEDS AI, I c. (NASDAQ:MEDS), fo me ly Wellgistics Health, I c., is a healthca e compa y focused o the ve tical i teg atio of tech ology, pha macy, pha maceutical-adjace t a d telemedici e busi ess u its th ough its health i fo matio tech ology platfo ms to delive a bette expe ie ce fo co sume s a d p ovide s. Headqua te ed i Tampa, Fla., DataMEDS i co po ates its Ei stei Rx™ a tificial i tellige ce platfo m a d Pha macyChai ™ blockchai -e abled sma t co t acts platfo m i to the Health Lives He e mobile applicatio f om Tollo Health, LLC, a d its pha macy- elated Co exa Health subsidia y p ovides pha macy dispe si g a d pha macy- elated se vices, i cludi g dist ibutio of p oducts developed by Tollo Health. DataMEDS also ow s Helomics Co po atio , a Pittsbu gh, PA-based comme cial cli ical molecula diag ostics labo ato y focused o the ChemoFx® Assay chemothe apy selectio diag ostics test that aims to help o cologists make chemothe apy t eatme t decisio s. Lea mo e at https://datamedsai.com.
Tollo Health, LLC is a healthca e compa y comme cializi g p op ieta y medical foods a d dieta y suppleme ts a d, th ough TolloBio, developi g biopha maceutical ca didates, alo gside its Health Lives He e mobile applicatio . Co exa Health, a subsidia y of DataMeds AI, I c., dist ibutes select Tollo Health medical foods a d dieta y suppleme ts u de a wholesale dist ibutio a a geme t.
This p ess elease co tai s fo wa d-looki g stateme ts withi the mea i g of the P ivate Secu ities Litigatio Refo m Act of 1995. These stateme ts a e based o ma ageme t’s cu e t expectatio s a d a e ot p edictio s of actual pe fo ma ce. Fo wa d-looki g stateme ts i clude, without limitatio , stateme ts ega di g: Co exa Pha macy’s ability to compou d, dispe se a d dist ibute the Six Peptides i complia ce with FDA’s e fo ceme t disc etio policy, Sectio 503A of the Fede al Food, D ug, a d Cosmetic Act a d state pha macy laws; the possibility that FDA o HHS may cha ge o withd aw the e fo ceme t disc etio policy, a d FDA’s fi al decisio s ega di g the 503A bulks list; the Compa y’s p ici g model a d the timi g a d complia ce of its ma keti g to p esc ibi g physicia s; physicia p esc ibi g dema d a d ma ket accepta ce of compou ded peptides; elia ce o thi d-pa ty supplie s a d pa t e pha macies, a d the quality a d availability of bulk d ug substa ces; ste ile compou di g complia ce, adve se eve ts a d p oduct liability; the Compa y’s pla s fo its pha macy hub a d dist ibutio wa ehouse, i cludi g equi ed lice su e; competitio f om othe compou di g pha macies a d f om u egulated esea ch-use-o ly p oducts; the accu acy of thi d-pa ty ma ket size estimates; elated-pa ty a a geme ts with Tollo Health, LLC; the Compa y’s ability to mai tai complia ce with Nasdaq listi g sta da ds; a d the Compa y’s liquidity, capital esou ces a d ability to fu d ope atio s. Actual esults may diffe mate ially f om those exp essed o implied i these fo wa d-looki g stateme ts due to a umbe of isks a d u ce tai ties, i cludi g those desc ibed u de “Risk Facto s” i the Compa y’s most ece t A ual Repo t o Fo m 10-K a d subseque t fili gs with the Secu ities a d Excha ge Commissio . Reade s a e cautio ed ot to place u due elia ce o these fo wa d-looki g stateme ts, which speak o ly as of the date of this p ess elease. The Compa y u de takes o obligatio to update o evise a y fo wa d-looki g stateme ts, except as equi ed by law.
###
View the o igi al p ess elease o ACCESS Newswi e
